CONSULTING AGREEMENTConsulting Agreement • June 7th, 2016 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledJune 7th, 2016 Company Industry JurisdictionPIVOT PHARMACEUTICALS INC., a British Columbia corporation having an address at 1275 West 6th Avenue, Vancouver, British Columbia V6H 1A6
DIRECTOR'S AGREEMENTDirector's Agreement • December 15th, 2015 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledDecember 15th, 2015 Company Industry JurisdictionPIVOT PHARMACEUTICALS INC., a corporation of the province of British Columbia with offices at 1275 West 6th Avenue, Vancouver, British Columbia, Canada V6H 1A6.
DIRECTOR’S AGREEMENTDirector's Agreement • March 26th, 2015 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 26th, 2015 Company Industry JurisdictionNEUROKINE PHARMACEUTICALS INC., a corporation of the province of British Columbia with offices at 1275 West 6th Avenue, Vancouver, British Columbia, Canada V6H 1A6.
PIVOT – ALTUM LICENSING AGREEMENTLicensing Agreement • September 13th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 13th, 2017 Company IndustryThis EXCLUSIVE LICENSING AGREEMENT is made this 12th day of September 2017 (hereinafter the “Effective Date”), by and between PIVOT PHARMACEUTICALS INC., a corporation organized under the laws of British Columbia with an address c/o Alexander Holburn Beaudin & Lang LLP at 2700-700 West Georgia Street, Vancouver, British Columbia V7Y 1B8 (hereinafter “PIVOT”) and ALTUM PHARMACEUTICALS INC., a corporation organized under the laws of British Columbia with an address c/o 1275 West 6th Street, Suite 300, Vancouver, BC V6C 1V5 (hereinafter “ALTUM”). PIVOT and ALTUM herein may be referred to individually as “Party” or together as “Parties.”
SHAREHOLDER’S AGREEMENTShareholder Agreement • August 7th, 2009 • Neurokine Pharmaceuticals Inc.
Contract Type FiledAugust 7th, 2009 CompanyNeurokine Pharmaceuticals Inc., a company incorporated under the laws of British Columbia having a registered office at Suite 1820 Cathedral Place 925 West Georgia Street Vancouver, BC V6C 3L2
THIS EMPLOYMENT AGREEMENT is as of the 1st day of February, 2016 BETWEEN:Employment Agreement • June 7th, 2016 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledJune 7th, 2016 Company Industry JurisdictionPIVOT PHARMACEUTICALS INC., a corporation incorporated pursuant to the laws of the Province of British Columbia and having an address of Suite 300, 1275 West 6th Avenue, Vancouver, B.C., Canada, V6C 1V5
Private Placement Subscription Agreement for Non U.S. Residents Name of Purchaser Hassan Salari (the “Purchaser”)Private Placement Subscription Agreement • August 12th, 2010 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledAugust 12th, 2010 Company IndustryThe Purchaser subscribes for and agrees to purchase from Neurokine Pharmaceutical Inc., a British Columbia (the "Company"), units with each unit (the “Unit”) consisting of one share of our common stock and one warrant, to purchase a quarter (¼) of a share of common stock of the Company at an exercise price of US$0.05 per share and in accordance other terms as set out in Schedule “D” hereto , to be recorded in the name of the Purchaser at the address set out above, all on the terms and subject to the conditions set forth in Schedule “A” attached hereto.
DIRECTOR’S AGREEMENTDirector's Agreement • August 7th, 2009 • Neurokine Pharmaceuticals Inc.
Contract Type FiledAugust 7th, 2009 CompanyNEUROKINE PHARMACEUTICALS INC., a corporation incorporated under the laws of British Columbia having its principal business office at 1275 West 6th Avenue, Vancouver, British Columbia, V6H 1A6
PIVOT – SOLMIC COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • December 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledDecember 15th, 2017 Company IndustryThis COLLABORATION AND LICENSE AGREEMENT is made this 23rd day of September 2017 (hereinafter the “Effective Date”), by and between PIVOT PHARMACEUTICALS INC., a corporation organized under the laws of British Columbia with an address c/o 1275 West 6th Street, Suite 300, Vancouver, BC V6C 1A6 (hereinafter “PIVOT”) and SolMic GmbH, a corporation organized under the laws of Germany with an address Merowingerplatz 1a, 40225 Dusseldorf, Germany, (hereinafter “SOLMIC”). PIVOT and SOLMIC herein may be referred to individually as “Party” or together as “Parties.”
THIS EMPLOYMENT AGREEMENT dated for reference March 1, 2018 BETWEEN:Employment Agreement • March 12th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 12th, 2018 Company Industry JurisdictionPIVOT PHARMACEUTICALS INC., a corporation amalgamated under the Canada Business Corporations Act and having its head office at #300-1275 West 6th Avenue, Vancouver, British Columbia Canada, V6H 1A6 (the “Company”)
DEBT FORGIVENESS AGREEMENTDebt Forgiveness Agreement • September 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledSeptember 15th, 2017 Company Industry JurisdictionThis Debt Forgiveness Agreement (“Agreement”), entered into effective July 31, 2017, by and between Pivot Pharmaceuticals Inc. (the “Company”) and Moira Ong (“Lender”), in reference to the following:
UNANIMOUS SHAREHOLDERS’ AGREEMENTShareholder Agreements • December 19th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • Quebec
Contract Type FiledDecember 19th, 2018 Company Industry JurisdictionNOW THEREFORE, this Agreement witnesses that for and in consideration of the mutual promises, covenants and agreements as hereinafter contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by each of the Parties, the Parties agree as follows:
DEBT FORGIVENESS AGREEMENTDebt Forgiveness Agreement • September 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledSeptember 15th, 2017 Company Industry JurisdictionThis Debt Forgiveness Agreement (“Agreement”), entered into effective July 31, 2017, by and between Pivot Pharmaceuticals Inc. (the “Company”) and Soho Capital Inc. (“Lender”), in reference to the following:
AGREEMENT AND PLAN OF MERGER AND ACQUISITION AGREEMENT AMONG PIVOT PHARMACEUTUCALS, INC. AND PIVOT PHARMA U.S. INC. AND INDUS PHARMACEUTICALS, INC., AND SINDU RESEARCH LABORATORIES PVT. LTD.Merger Agreement • November 23rd, 2015 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 23rd, 2015 Company Industry JurisdictionThis Merger Agreement (this ''Agreement'') is entered into as of November 4, 2015, by and among Pivot Pharmaceuticals, Inc. a British Columbia Corporation with its principal place of business located at 1275 West 6th Avenue, Vancouver, B.C., Canada, V6H 1A6 ("Buyer"), Pivot Pharma U.S. Inc., a Delaware corporation and a wholly owned Subsidiary of Buyer ("Merger Subsidiary"), IndUS Pharmaceuticals, Inc., a Delaware corporation ("Seller"), Sindu Research Laboratories Pvt Ltd., a corporation formed under the laws of India ("Sindu") and the Sindu Stockholders (as defined below). Buyer, Merger Subsidiary, Seller and Sindu are referred to collectively herein as the "Parties".
MANAGEMENT CONSULTING AGREEMENTManagement Consulting Agreement • August 7th, 2009 • Neurokine Pharmaceuticals Inc. • British Columbia
Contract Type FiledAugust 7th, 2009 Company Jurisdiction
MASTER SERVICE AGREEMENTMaster Service Agreement • December 3rd, 2009 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledDecember 3rd, 2009 Company Industry JurisdictionThis Master Service Agreement (the “Agreement”) is made as of October 2, 2007 (the “Effective Date”) between Northern Lipids Inc., a contract research organization, with its principal place of business located at BC Research Institute, 3650 Wesbrook Mall, Vancouver B.C., Canada V6S 2L2 (“NLI”), and Neurokine Pharmaceuticals Inc. with its principal place of business located at 1275 West 6th Avenue, Vancouver, B.C. Canada (“Developer”).
EXCHANGE AGREEMENTExchange Agreement • March 12th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 12th, 2018 Company Industry JurisdictionTHRUDERMIC LLC, a limited liability company incorporated pursuant to the laws of North Carolina and having an address at 4843 Gate Post Lane, Wilmington, NC 28412
The GLOBE LABORATORIES INC. NON-EXCLUSIVE LICENSE AGREEMENT Agreement June 17, 2008Non-Exclusive License Agreement • December 3rd, 2009 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledDecember 3rd, 2009 Company Industry JurisdictionThis License Agreement (“AGREEMENT”) is made as of the 17 day of June, 2008 (“EFFECTIVE DATE”), between Globe Laboratories Inc., a British Columbia corporation, having a principal place of business at 2386 East Mall, Suite 307, Vancouver, BC. V6T 1Z3 (“LICENSOR”) and Neurokine Pharmaceuticals Inc. (“LICENSEE), a British Columbia Corporation, having a business office at…1255 West Pender Street, Vancouver, B.C. V6E 2V1, each referred to herein individually as a “PARTY” and collectively as the “PARTIES”.
BINDING LETTER OF INTENT – TECHNOLOGY LICENSING AGREEMENTTechnology Licensing Agreement • December 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledDecember 15th, 2017 Company IndustryFIELD Pivot wishes to acquire worldwide rights for the development and commercialization of Thrudermic Nano Technology for all cannabinoids.
DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • December 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledDecember 15th, 2017 Company Industry JurisdictionPivot Pharmaceuticals Inc., a company incorporated under the laws of British Columbia and having its head office located at 1275 West 6th Avenue, Suite 300, Vancouver, BC Canada V6H 1A6
SUBSCRIPTION AGREEMENT – DEBT SETTLEMENTSubscription Agreement • December 16th, 2013 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledDecember 16th, 2013 Company Industry JurisdictionAhmad Doroudian (the “Subscriber”) wishes to subscribe for 35,000,000 shares of common stock in the capital stock of the Company (the “Shares”), at a deemed price of $0.001 per Share, for an aggregate cost of $35,000;
ContractRoyalty Agreement • March 12th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 12th, 2018 Company Industry JurisdictionTHIS ROYALTY AGREEMENT (this “ Agreement ”) is entered into as of March 1, 2018 (the “ Effective Date ”), by and between Pivot Pharmaceuticals Inc., a corporation amalgamated under the Canada Business Corporations Act and having its head office at #300-1275 West 6th Avenue, Vancouver, British Columbia Canada, V6H 1A6 , (“ Company ” or “ Pivot ”), and AquaBrew Inc., a California corporation doing business as “Cafejo” (“ Cafejo ”). Pivot and Cafejo are sometimes referred to herein individually as a “ Party ” and collectively as “ Parties .”
EXCHANGE AGREEMENTExchange Agreement • March 12th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 12th, 2018 Company Industry JurisdictionERS HOLDINGS, LLC, a limited liability company incorporated pursuant to the laws of California and having an address at 11138 Del Amo Blvd #129, Lakewood, CA 90715
EMPLOYMENT AGREEMENTEmployment Agreement • December 15th, 2015 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledDecember 15th, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the "Agreement") is effective the 20th day of November, 2015 (the "Effective Date"), by and between Pivot Pharmaceuticals, Inc., a British Columbia corporation (the "Company") and Pravin Chaturvedi (the "Executive").
CONSULTING AGREEMENTConsulting Agreement • March 26th, 2015 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 26th, 2015 Company Industry JurisdictionNEUROKINE PHARMACEUTICALS INC., a British Columbia corporation having an address at 1275 West 6th Avenue, Vancouver, British Columbia V6H 1A6
EXCHANGE AGREEMENTExchange Agreement • September 13th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 13th, 2017 Company Industry JurisdictionTHIS EXCHANGE AGREEMENT (this “Agreement”) is made as of September 11, 2017, by and among PIVOT PHARMACEUTICALS INC., a British Columbia Corporation (“PIVOT”), INDUS PHARMACEUTICALS, INC., a Delaware General Business Corporation (“INDUS” or the “COMPANY”) and PRAVIN CHATURVEDI (“CHATURVEDI”). Capitalized terms used and not otherwise defined herein have the meanings set forth in ARTICLE X.
Wakabayashi Fund, LLC Japanese Limited Liability Company, Address: 4-13-20 Mita Minato-Ku, Tokyo, Japan 108-0073 Hereinafter referred to as “WAKABAYASHI” or “Consultant” And NEUROKINE PHARMACEUTICALS, INC. A Vancouver, BC Corporation, its agents,...Consulting Agreement • August 29th, 2011 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 29th, 2011 Company Industry JurisdictionWhereas Consultant is in the business of providing management consulting services to businesses in an effort to obtain institutional capital from third parties for business use, including equipment leasing, purchase order and/ or contract financing, factoring and financing for land and buildings’ utilizing various financing instruments and whereas Client desires to retain Consultant for the following purposes:
THE GLOBE LABORATORIES INC. NON-EXCLUSIVE LICENSE AGREEMENT Agreement June 17, 2008Non-Exclusive License Agreement • August 7th, 2009 • Neurokine Pharmaceuticals Inc. • British Columbia
Contract Type FiledAugust 7th, 2009 Company Jurisdiction